XML 24 R7.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Feb. 02, 2019
Feb. 03, 2018
OPERATING ACTIVITIES:    
Net loss $ (97,382) $ (42,553)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of fixed assets 5,226 10,272
Amortization of intangible assets 3,890 3,890
Amortization of lease valuations   (20)
Stock based compensation 3,032 3,067
Treasury stock received for payment of withholding tax on exercises of RSUs (21)  
Adjustment to contingent consideration (272) (3,280)
Loss on disposal of fixed assets 422 579
Loss on impairment of goodwill and long lived assets 59,658 29,107
Change in cash surrender value 78 (399)
Gain on life insurance asset   (8,733)
Changes in operating assets and liabilities that provide (use) cash:    
Accounts receivable (914) 2,616
Merchandise inventory 14,535 16,892
Prepaid expenses and other current assets 319 1,295
Other long-term assets 6 (668)
Accounts payable (7,451) (10,527)
Accrued expenses and other current liabilities (1,134) 1,648
Deferred revenue (1,509) (1,293)
Other long-term liabilities (4,001) (1,906)
Net cash used in operating activities (25,518) (13)
INVESTING ACTIVITIES:    
Purchases of fixed assets (3,689) (8,407)
Proceeds from company owned life insurance   14,363
Investment in joint venture   (2,575)
Capital distributions from joint venture 1,347 1,101
Net cash (used in) provided by investing activities (2,342) 4,482
FINANCING ACTIVITIES:    
Exercise of equity awards, net of treasury shares received 80  
Vesting of long term equity awards   (39)
Payments of long term borrowings (35,734) (11,657)
Proceeds from long term borrowings 35,734 11,657
Payments to etailz shareholders (1,500) (5,000)
Purchase of treasury stock   (1)
Net cash used in financing activities (1,420) (5,040)
Net decrease in cash, cash equivalents, and restricted cash (29,280) (571)
Cash, cash equivalents, and restricted cash, beginning of year 43,506 44,077
Cash, cash equivalents, and restricted cash, end of year 14,226 43,506
Supplemental disclosures and non-cash investing and financing activities:    
Interest paid 723 332
Issuance of restricted performance based awards / deferred / restricted shares under deferred / restricted stock agreements $ 109 $ 120